FDA Inspection 1094266 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Jun 24, 2019 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 24, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Brunswick, NJ (United States)